BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON: Form 990, tax year 2015
View the entire original 990 at ProPublica ↗
- Organization
- BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON (EIN 91-0653422)
- Tax period
- 2015-01-01 to 2015-12-31
- Filed
- 2016-11-10
- IRS object ID
- 201613159349302971
- Schema version
- 2015v2.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule K
- Schedule M
- Schedule O
- Schedule R
- Affiliated Group Schedule
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2016-11-10T12:05:12-00:00 | ReturnTs |
| Tax Period End | 2015-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KPMG LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1918 8th Avenue Suite 2900 | AddressLine1Txt |
| City | Seattle | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98101 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2015-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 910653422 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Benaroya Research Institute at Virginia Mason | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | BENA | BusinessNameControlTxt |
| Phone | 2063426500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1201 Ninth Avenue | AddressLine1Txt |
| City | Seattle | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 981012795 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Homer W Lane Jr | PersonNm |
| Person Title | Executive DirectorCFO | PersonTitleTxt |
| Signature | 2016-11-09 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Sue Robison | PreparerPersonNm |
| Phone | 2069134000 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2015 | TaxYr |
| Build TS | 2017-02-10 21:41:12Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | Gerald Nepom MD PhD | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1201 Ninth Avenue | AddressLine1Txt |
| City | Seattle | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98101 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $67,161,738 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | http://www.benaroyaresearch.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1956 | FormationYr |
| Legal Domicile State | WA | LegalDomicileStateCd |
| Activity Or Mission | To conduct and encourage high quality medical, surgical, and scientific research and research training in disease and problems of medical importance. | ActivityOrMissionDesc |
| Voting Members Governing Body | 22 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 17 | VotingMembersIndependentCnt |
| Total Employee | 326 | TotalEmployeeCnt |
| Total Volunteers | 9 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| PY Contributions Grants | $54,174,085 | PYContributionsGrantsAmt |
| CY Contributions Grants | $59,709,893 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $6,639,555 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $7,021,290 | CYProgramServiceRevenueAmt |
| PY Investment Income | $164,405 | PYInvestmentIncomeAmt |
| CY Investment Income | -$107,705 | CYInvestmentIncomeAmt |
| PY Other Revenue | $350,163 | PYOtherRevenueAmt |
| CY Other Revenue | $347,680 | CYOtherRevenueAmt |
| PY Total Revenue | $61,328,208 | PYTotalRevenueAmt |
| CY Total Revenue | $66,971,158 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $17,599,162 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $23,704,570 | CYGrantsAndSimilarPaidAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $25,135,170 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $25,752,883 | CYSalariesCompEmpBnftPaidAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $19,170,074 | PYOtherExpensesAmt |
| CY Other Expenses | $18,024,768 | CYOtherExpensesAmt |
| PY Total Expenses | $61,904,406 | PYTotalExpensesAmt |
| CY Total Expenses | $67,482,221 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$576,198 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$511,063 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $85,390,333 | TotalAssetsBOYAmt |
| Total Assets EOY | $85,438,161 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $43,346,845 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $45,136,173 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $42,043,488 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $40,301,988 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | See Schedule O | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $27,986,467 | ExpenseAmt |
| Grant | $20,372,963 | GrantAmt |
| Desc | Immune Tolerance Network Program. See Schedule O. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $9,094,684 | ExpenseAmt |
| Grant | $2,356,655 | GrantAmt |
| Desc | Translational Program. See Schedule O. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $6,554,218 | ExpenseAmt |
| Grant | $363,343 | GrantAmt |
| Desc | Diabetes Program. See Schedule O. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $13,367,403 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $611,609 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $7,021,290 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $57,002,772 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (true) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | false | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | false | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | false | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | Yes (true) | TaxExemptBondsInd |
| Invest Tax Exempt Bonds | false | InvestTaxExemptBondsInd |
| Escrow Account | false | EscrowAccountInd |
| On Behalf Of Issuer | Yes (true) | OnBehalfOfIssuerInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | false | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 102 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 326 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 22 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 17 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (true) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Homer W Lane Jr Executive DirectorC | PersonNm |
| Phone | 2063426508 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1201 Ninth Avenue | AddressLine1Txt |
| City | Seattle | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 981012795 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (28 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| Carla Greenbaum MD | ||||||||
| Director | 040.00 | Yes (X) | $212,388 | $0 | $30,886 | |||
| Gerald Nepom MD PhD | ||||||||
| Ex Officio, Director | 040.00 | Yes (X) | $479,083 | $0 | $44,592 | Yes (X) | ||
| Joyce Lammert MD PhD | ||||||||
| Director | 001.00 | Yes (X) | $0 | $575,689 | $92,758 | 050.00 | ||
| John Corman MD | ||||||||
| Director | 001.00 | Yes (X) | $0 | $524,046 | $39,354 | 050.00 | ||
| Gary Kaplan MD | ||||||||
| Director | 001.00 | Yes (X) | $0 | $1,463,343 | $1,123,646 | 054.00 | ||
| Tom Cohen | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Rebecca Campbell | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Kristi Pangrazio | ||||||||
| Director, Chairman | 001.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | 004.00 | |
| Margaret Morrow | ||||||||
| Director, Secretary | 001.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| Frank Dvorak PhD | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Trish Markey | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Edward Drosdick | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| David Williams | ||||||||
| Director, Treasurer | 001.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| Ditman Johnson | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Michael Gallatin | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Jessica Muffett | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Carla DewBerry | ||||||||
| Director, Vice-Chair | 001.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| Ann Sobil | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Christopher Wilson MD | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Nabil Istafanous | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Ben Reiber | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Catherine Zimmerman | ||||||||
| Director | 001.00 | Yes (X) | $0 | $0 | $0 | |||
| Homer Lane Jr | ||||||||
| Executive Director, Chief Financial Officer | 040.00 | $307,405 | $0 | $32,594 | Yes (X) | |||
| Jane Buckner MD | ||||||||
| Research Member | 040.00 | $259,514 | $0 | $26,892 | Yes (X) | |||
| William Kwok PhD | ||||||||
| Research Member | 040.00 | $216,831 | $0 | $26,892 | Yes (X) | |||
| Lynn Rose | ||||||||
| Director Scientific Administration | 040.00 | $182,021 | $0 | $23,520 | Yes (X) | |||
| Steven Ziegler PhD | ||||||||
| Research Member | 040.00 | $189,110 | $0 | $18,496 | Yes (X) | |||
| James Lord MD | ||||||||
| Research Member | 040.00 | $202,127 | $0 | $21,438 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,048,479 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $2,563,078 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $1,481,068 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 35 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (2 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| Insight Globall LLC | |||||
| PO Box 198226 | Atlanta | GA | 30384 | Consulting | $198,540 |
| KPMG LLP | |||||
| 1918 Eighth Ave Suite 2900 | Seattle | WA | 98101 | Auditing Consulting | $105,381 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 2 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $3,500,000 | RelatedOrganizationsAmt |
| Government Grants | $46,581,827 | GovernmentGrantsAmt |
| All Other Contributions | $9,628,066 | AllOtherContributionsAmt |
| Noncash Contributions | $85,000 | NoncashContributionsAmt |
| Total Contributions | $59,709,893 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| Commercial Studies | 621500 | $4,028,943 | $4,028,943 |
| Collaborative research core services | 621500 | $2,992,347 | $2,992,347 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $7,021,290 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$107,705 | TotalRevenueColumnAmt |
| Exclusion | -$107,705 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $538,260 | RealAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $190,580 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $347,680 | RealAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $347,680 | TotalRevenueColumnAmt |
| Exclusion | $347,680 | ExclusionAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $66,971,158 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $7,021,290 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $239,975 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,239,142 | TotalAmt |
| Program Services | $21,239,142 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,465,428 | TotalAmt |
| Program Services | $2,465,428 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,039,840 | TotalAmt |
| Program Services | $1,265,487 | ProgramServicesAmt |
| Management And General | $774,353 | ManagementAndGeneralAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $17,213,070 | TotalAmt |
| Program Services | $12,770,397 | ProgramServicesAmt |
| Management And General | $4,442,673 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,436,495 | TotalAmt |
| Program Services | $1,015,651 | ProgramServicesAmt |
| Management And General | $420,844 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,740,387 | TotalAmt |
| Program Services | $2,644,581 | ProgramServicesAmt |
| Management And General | $1,095,806 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,323,091 | TotalAmt |
| Program Services | $935,471 | ProgramServicesAmt |
| Management And General | $387,620 | ManagementAndGeneralAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,322 | TotalAmt |
| Management And General | $7,322 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $91,100 | TotalAmt |
| Management And General | $91,100 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fees For Services Prof Fundraising | FeesForServicesProfFundraising |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,592,679 | TotalAmt |
| Program Services | $2,046,908 | ProgramServicesAmt |
| Management And General | $545,771 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $197,419 | TotalAmt |
| Program Services | $7,000 | ProgramServicesAmt |
| Management And General | $190,419 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $152,153 | TotalAmt |
| Program Services | $58,480 | ProgramServicesAmt |
| Management And General | $93,673 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,116,074 | TotalAmt |
| Program Services | $271,542 | ProgramServicesAmt |
| Management And General | $844,532 | ManagementAndGeneralAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,760,019 | TotalAmt |
| Program Services | $2,395,025 | ProgramServicesAmt |
| Management And General | $364,994 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $350,180 | TotalAmt |
| Program Services | $315,161 | ProgramServicesAmt |
| Management And General | $35,019 | ManagementAndGeneralAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $144,822 | TotalAmt |
| Program Services | $125,156 | ProgramServicesAmt |
| Management And General | $19,666 | ManagementAndGeneralAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $812,900 | TotalAmt |
| Program Services | $707,223 | ProgramServicesAmt |
| Management And General | $105,677 | ManagementAndGeneralAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,505,374 | TotalAmt |
| Program Services | $2,854,002 | ProgramServicesAmt |
| Management And General | $651,372 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $44,744 | TotalAmt |
| Management And General | $44,744 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| Supplies | $3,597,857 | $3,528,154 | $69,703 |
| Other Purchased Services | $311,275 | $191,582 | $119,693 |
| Patient Costs | $1,216,493 | $1,216,493 | |
| Research Participants Fee | $404,728 | $404,728 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $719,629 | TotalAmt |
| Program Services | $545,161 | ProgramServicesAmt |
| Management And General | $174,468 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $67,482,221 | TotalAmt |
| Program Services | $57,002,772 | ProgramServicesAmt |
| Management And General | $10,479,449 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,549,793 | BOYAmt |
| EOY | $9,334,155 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $747,735 | BOYAmt |
| EOY | $6,095 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,311,167 | BOYAmt |
| EOY | $11,688,324 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $314,740 | BOYAmt |
| EOY | $854,913 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $505,401 | BOYAmt |
| EOY | $454,115 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $70,056,830 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $39,101,568 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $32,304,086 | BOYAmt |
| EOY | $30,955,262 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,505,508 | BOYAmt |
| EOY | $9,139,241 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $21,252,233 | BOYAmt |
| EOY | $22,130,376 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $899,670 | BOYAmt |
| EOY | $875,680 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $85,390,333 | BOYAmt |
| EOY | $85,438,161 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,220,796 | BOYAmt |
| EOY | $12,044,459 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,074,559 | BOYAmt |
| EOY | $4,410,224 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,755,000 | BOYAmt |
| EOY | $9,425,000 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $19,296,490 | BOYAmt |
| EOY | $19,256,490 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $43,346,845 | BOYAmt |
| EOY | $45,136,173 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $24,026,666 | BOYAmt |
| EOY | $20,378,881 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,864,453 | BOYAmt |
| EOY | $8,690,843 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,152,369 | BOYAmt |
| EOY | $11,232,264 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $42,043,488 | BOYAmt |
| EOY | $40,301,988 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $85,390,333 | BOYAmt |
| EOY | $85,438,161 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$511,063 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$1,230,437 | NetUnrlzdGainsLossesInvstAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Medical Research Organization | Yes (X) | MedicalResearchOrganizationInd |
Hospital Name And Address HospitalNameAndAddressGrp
Supported Organization Name SupportedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Virginia Mason Medical Center | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| City | Seattle | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $34,328,409 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $38,329,362 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $44,973,133 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $54,174,085 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $59,709,893 | CurrentTaxYearAmt |
| Total | $231,514,882 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $34,328,409 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $38,329,362 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $44,973,133 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $54,174,085 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $59,709,893 | CurrentTaxYearAmt |
| Total | $231,514,882 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $25,966,127 | SubstantialContributorsTotAmt |
| Public Support Total170 | $205,548,755 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,724,806 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $560,734 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $642,011 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $707,157 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $430,555 | CurrentTaxYearAmt |
| Total | $4,065,263 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,391,006 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $4,701,834 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $6,122,655 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $6,639,555 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $7,021,290 | CurrentTaxYearAmt |
| Total | $26,876,340 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $262,456,485 | TotalSupportAmt |
| Public Support CY170 | 0.78320 | PublicSupportCY170Pct |
| Public Support PY170 | 0.74980 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
| Public Support CY509 | 0.00000 | PublicSupportCY509Pct |
| Investment Income CY | 0.00000 | InvestmentIncomeCYPct |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Belongs Afflt Grp | Yes (X) | OrganizationBelongsAffltGrpInd |
Total Grassroots Lobbying TotalGrassrootsLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Affiliated Group Total | $108,173 | AffiliatedGroupTotalAmt |
Total Direct Lobbying TotalDirectLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Affiliated Group Total | $46,593 | AffiliatedGroupTotalAmt |
Total Lobbying Expend TotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Affiliated Group Total | $154,766 | AffiliatedGroupTotalAmt |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $67,482,221 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $1,112,971,638 | AffiliatedGroupTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $67,482,221 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $1,113,126,404 | AffiliatedGroupTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $1,000,000 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $1,000,000 | AffiliatedGroupTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $250,000 | FilingOrganizationsTotalAmt |
| Affiliated Group Total | $250,000 | AffiliatedGroupTotalAmt |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $1,000,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $1,000,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $1,000,000 | CurrentYearMinus1Amt |
| Current Year | $1,000,000 | CurrentYearAmt |
| Total | $4,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmt |
Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $133,874 | CurrentYearMinus3Amt |
| Current Year Minus2 | $122,035 | CurrentYearMinus2Amt |
| Current Year Minus1 | $138,835 | CurrentYearMinus1Amt |
| Current Year | $154,766 | CurrentYearAmt |
| Total | $549,510 | TotalAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $250,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $250,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $250,000 | CurrentYearMinus1Amt |
| Current Year | $250,000 | CurrentYearAmt |
| Total | $1,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,000 | GrassrootsCeilingAmt |
Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $127,874 | CurrentYearMinus3Amt |
| Current Year Minus2 | $114,035 | CurrentYearMinus2Amt |
| Current Year Minus1 | $119,335 | CurrentYearMinus1Amt |
| Current Year | $108,173 | CurrentYearAmt |
| Total | $469,417 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | false | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | false | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | false | DirectContactLegislatorsInd |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | false | OtherActivitiesInd |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
| Form4720 Filed4912 Tax | false | Form4720Filed4912TaxInd |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| II-A A | Benaroya Research Institute at Virginia Mason, EIN 91-0653422, 1201 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0. |
| II-A A continued | Virginia Mason Health System, EIN 91-1351110, 1100 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures. Excess Lobbying Expenditures 0 |
| II-A A continued | Virginia Mason Institute, EIN 26-3763656, 1100 Ninth Avenue, Seattle, WA 98101. Non-electing member. 0 Lobbying Expenditures, 0 Excess Lobbying Expenditures. |
| II-A A continued | Virginia Mason Medical Center, EIN 91-0565539, 1100 Ninth Avenue, Seattle, WA 98101. Electing member. Grassroots Lobbying Expenditures 108,173 Direct Lobbying Expenditures 46,593. Excess Lobbying Expenditures 0. Tax year ending December 31, 1998 was the first year in which Virginia Mason Medical Center made the election under Section 501h. The election was not revoked before the start of the tax year ending December 31, 2015. |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Incl Escrow Custodial Acct Liab | false | InclEscrowCustodialAcctLiabInd |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | Yes (true) | EndowmentsHeldRelatedOrgInd |
| Related Org List Sch R | Yes (true) | RelatedOrgListSchRInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $756,906 | OtherCostOrOtherBasisAmt |
| Book Value | $756,906 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $48,672,224 | OtherCostOrOtherBasisAmt |
| Depreciation | $22,940,313 | DepreciationAmt |
| Book Value | $25,731,911 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $196,862 | OtherCostOrOtherBasisAmt |
| Depreciation | $196,862 | DepreciationAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $19,856,562 | OtherCostOrOtherBasisAmt |
| Depreciation | $15,964,393 | DepreciationAmt |
| Book Value | $3,892,169 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $574,276 | OtherCostOrOtherBasisAmt |
| Book Value | $574,276 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $30,955,262 | TotalBookValueLandBuildingsAmt |
Other Securities OtherSecuritiesGrp (3 entries)
| DescDesc | Book ValueBookValueAmt | Method ValuationMethodValuationCd |
|---|---|---|
| Financial derivatives and other financial products | ||
| Closely-held equity interests | ||
| Interest in Net Assets of Virginia Mason Health System | $22,130,376 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $22,130,376 | TotalBookValueSecuritiesAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | Federal income taxes | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Rev Etc Audited Fincl Stmt | $65,740,721 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$1,230,437 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | -$1,230,437 | RevenueNotReportedAmt |
| Revenue Subtotal | $66,971,158 | RevenueSubtotalAmt |
| Total Revenue Per Form990 | $66,971,158 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $67,482,221 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Subtotal | $67,482,221 | ExpensesSubtotalAmt |
| Total Expenses Per Form990 | $67,482,221 | TotalExpensesPerForm990Amt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (4 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|
| East Asia and the Pacific | Conferences | Medical Research | $5,551 |
| Europe Including Iceland and Greenland | Conferences | Medical Research | $43,627 |
| North America | Conferences | Medical Research | $1,244 |
| South America | Conferences | Medical Research | $1,647 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Spent | $52,069 | SubtotalSpentAmt |
| Total Spent | $52,069 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (9 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| Europe Including Iceland and Greenland | Medical Research | $3,843 | Wire Transfer |
| Europe Including Iceland and Greenland | Medical Research | $748,064 | Wire Transfer |
| Europe Including Iceland and Greenland | Medical Research | $1,058,740 | Wire Transfer |
| Europe Including Iceland and Greenland | Medical Research | $162,417 | Wire Transfer |
| North America | Medical Research | $243,492 | Wire Transfer |
| North America | Medical Research | $37,556 | Wire Transfer |
| North America | Medical Research | $9,704 | Wire Transfer |
| North America | Medical Research | $176,636 | Wire Transfer |
| North America | Medical Research | $24,976 | Wire Transfer |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Org | 9 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | false | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Part I Line 2 | Subrecipient Monitoring Policy - medical research sub awards - BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing Federal Grants. The Subrecipient Monitoring policy provides assurance that subrecipients comply with Federal Grant regulations. This policy sets the criteria to establish eligibility of subrecipients to provide annual audited financial reports and the annual OMB single audit report that identify compliance with federal laws and regulations. The reports are analyzed with emphasis on auditors assessment of subrecipient internal controls and a standardized Risk Assessment is presented to management on each subrecipient. A Management Letter is issued to each subrecipient showing any findings on their OMB single audit report, and measurements are set for increased monitoring when an elevated level of risk is established. Management has communicated with an educated administrative staff regarding implementation of this policy. The Director of Grants and Contracts is responsible for monitoring subrecipient adherence to financial regulations. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. If there are unusual or unforeseen items, these will be investigated. |
| Part I Line 3f | The expenditures were actual expenses incurred in the region based on individual expense reports and tracking of expenditures by grant or department on the accrual basis of accounting. |
| Part II Line 1 | The expenditures were expenses incurred in the region based on award goals on the accrual basis of accounting. |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (74 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| Ann&Robert H Lurie Children's Hospital of Chicago | |||||||
| 225 East Chicago Ave No 205 | Chicago | IL | 606112991 | 362170833 | 501c3 | $46,651 | Medical Research |
| Arizona State University | |||||||
| Office for Research and Sponsored P | Tempe | AZ | 852876011 | 860196696 | Arizona | $17,354 | Medical Research |
| Arkansas Children's Hospital Research Institute | |||||||
| Financial Services Slot 663 attn Am | Little Rock | AR | 722023591 | 710694931 | 501c3 | $223,161 | Medical Research |
| Asthma Inc | |||||||
| 9725 3rd Ave NE Suite 500 | Seattle | WA | 98115 | 237219813 | 501c3 | $154,854 | Medical Research |
| Baylor College of Medicine | |||||||
| One Baylor Plaza Suite 600-D | Houston | TX | 770303411 | 741613878 | 501c3 | $11,434 | Medical Research |
| Brigham And Women's Hospital | |||||||
| Bank of America NA POBox 3887 | Boston | MA | 022413887 | 042312909 | 501c3 | $92,559 | Medical Research |
| Case Western Reserve University | |||||||
| 2123 Martin Luther King Drive Glenn | Cleveland | OH | 44106 | 341018992 | 501c3 | $24,710 | Medical Research |
| Cedars-Sinai Medical Center | |||||||
| Sponsored Research and Fund Adminst | Los Angeles | CA | 900481804 | 951643307 | 501c3 | $237,343 | Medical Research |
| Columbia University Trustees of | |||||||
| PO Box 29789 General Post Office | New York | NY | 100879789 | 135598093 | 501c3 | $194,145 | Medical Research |
| Dana-Farber Cancer Institute Inc | |||||||
| 450 Brookline Ave 431C | Boston | MA | 02215 | 042263040 | 501c3 | $22,932 | Medical Research |
| Dermatology Research Assoc Inc | |||||||
| 301 Carriage Place | Manhatten Beach | CA | 90266 | 273947370 | $74,048 | Medical Research | |
| Duke University | |||||||
| Cell Biology Jenkins/Hogan | Durham | NC | 27710 | 560532129 | 501c3 | $389,699 | Medical Research |
| Emory University | |||||||
| 1599 Clifton Road NE 4th floor | Atlanta | GA | 30322 | 580566256 | 501c3 | $432,272 | Medical Research |
| Feinstein Institute for Medical Research | |||||||
| 350 Community Drive | Manhasset | NY | 11030 | 112673595 | 501c3 | $30,048 | Medical Research |
| Fred Hutchinson Cancer Research Center | |||||||
| 1100 Fairview Ave N J6-330 PO Box 1 | Seattle | WA | 981091024 | 237156071 | 501c3 | $91,156 | Medical Research |
| Hospital for Special Surgery | |||||||
| 535 East 70th Street | New York | NY | 10021 | 131624135 | 501c3 | $17,233 | Medical Research |
| Icahn School of Medicine at Mount Sinai | |||||||
| 101 Woodruff Circle - 7126 WMRB Att | Atlanta | GA | 30322 | 580566256 | 501c3 | $389,327 | Medical Research |
| Indiana University | |||||||
| 620 Union Drive Room 618 | Indianapolis | IN | 462025167 | 356001673 | 501c3 | $24,462 | Medical Research |
| Johns Hopkins University | |||||||
| Department of Pediatrics 400 N Wolf | Baltimore | MD | 21287 | 520595110 | 501c3 | $686,775 | Medical Research |
| Jonathan Corren MD Inc | |||||||
| 10780 Santa Monica Blvd 280 Allergy | Los Angeles | CA | 90025 | 462346264 | $205,667 | Medical Research | |
| Joslin Diabetes Center | |||||||
| One Joslin Place | Boston | MA | 02215 | 042203836 | 501c3 | $6,954 | Medical Research |
| La Jolla Institute for Allergy & Immunology | |||||||
| 9420 Athena Circle | La Jolla | CA | 92037 | 330328688 | 501c3 | $133,404 | Medical Research |
| Louisiana State University Health Sciences Center | |||||||
| 1501 Kings Highway | Shreveport | LA | 711303932 | 720702002 | Louisiana | $12,477 | Medical Research |
| Massachusetts General Hospital | |||||||
| Bank of America NA PO Box 414876 | Boston | MA | 02241 | 041564655 | 501c3 | $5,123,674 | Medical Research |
| Mayo Clinic | |||||||
| 200 First Street Southwest | Rochester | MN | 55905 | 416011702 | 501c3 | $6,862 | Medical Research |
| Medical University of South Carolina | |||||||
| 19 Hagood Avenue Ste 604 MSC 808 | Charleston | SC | 29425 | 576000722 | South Carolina | $19,412 | Medical Research |
| National Jewish Health | |||||||
| 1400 Jackson Street M213 | Denver | CO | 80206 | 742044647 | 501c3 | $58,660 | Medical Research |
| New York University School of Medicine | |||||||
| 1 Park Ave Fl 11 | New York | NY | 10016 | 135562308 | 501c3 | $30,637 | Medical Research |
| New York University-School of Medicine | |||||||
| Bank of America PO Box 415026 | Boston | MA | 022415026 | 135562308 | 501c3 | $44,937 | Medical Research |
| Newport Beach Clinical Research Associates Inc | |||||||
| 3900 West Coast Hwy Suite 330 | Newport Beach | CA | 92663 | 204957981 | $13,902 | Medical Research | |
| Northwestern University | |||||||
| 750 N Lake Shore Drive | Chicago | IL | 60611 | 362167817 | 501c3 | $257,253 | Medical Research |
| Norton Neurosciences InstituteCommunity Med Assoc | |||||||
| 224 East Broadway 7th floor | Louiseville | KY | 402022025 | 611276316 | 501c3 | $9,109 | Medical Research |
| Ohio State University | |||||||
| Office of Sponsored Programs 1960 K | Columbus | OH | 43210 | 316025986 | 501c3 | $39,878 | Medical Research |
| Oklahoma Medical Research Foundation | |||||||
| 825 NE 13th Street | Oklahoma City | OK | 73104 | 730580274 | 501c3 | $43,026 | Medical Research |
| Polyclinic | |||||||
| Madison Center 904 7th Ave 6th Floo | Seattle | WA | 98104 | 910369070 | $27,736 | Medical Research | |
| Rockefeller University | |||||||
| 1230 York Ave Financial Post Award | New York | NY | 100656307 | 131624158 | 501c3 | $185,983 | Medical Research |
| Rogosin Institute | |||||||
| 504 East 74th St 5th floor | New York | NY | 100214782 | 133184198 | 501c3 | $20,525 | Medical Research |
| Rutgers the State University of New Jersey | |||||||
| Office of Research and Sponsored Pr | New Brunswick | NJ | 089018559 | 910961784 | 501c3 | $428,510 | Medical Research |
| Sanford Research | |||||||
| 2301 E 60th St N Attn Clinical Rese | Sioux Falls | SD | 57104 | 460450378 | 501c3 | $15,618 | Medical Research |
| Seattle Childrens Hospital | |||||||
| PO Box 24728 | Seattle | WA | 981240728 | 910564748 | 501c3 | $796,029 | Medical Research |
| South Suburban Neurology | |||||||
| 3235 Vollmer Rd 110 | Flossmoor | IL | 60422 | 363142574 | $13,180 | Medical Research | |
| St Jude Children's Research Hospital Inc | |||||||
| PO Box 1000 Dept 949 | Memphis | TN | 381480949 | 620646012 | 501c3 | $86,444 | Medical Research |
| Stanford University | |||||||
| PO Box 44253 | San Francisco | CA | 941444253 | 941156365 | 501c3 | $1,055,572 | Medical Research |
| Sutter East Bay Hospitals | |||||||
| PO Box 742585 | Los Angeles | CA | 900742585 | 941196176 | 501c3 | $12,334 | Medical Research |
| Tulane University | |||||||
| 1430 Tulane Ave Dermatology 8036 At | New Orleans | LA | 70112 | 720423889 | 501c3 | $32,326 | Medical Research |
| UC Regents University California SanDiego | |||||||
| UCSD Central Cashier 9500 Gilman Dr | La Jolla | CA | 920930009 | 426004813 | 501c3 | $532,975 | Medical Research |
| Univ of Minnesota Regents | |||||||
| 450 McNamara Alumni Center | Minneapolis | MN | 554552070 | 416007513 | Minnesota | $10,423 | Medical Research |
| Univ of Texas SW Med Ctr | |||||||
| Grants Management PO Box 841753 | Dallas | TX | 752841753 | 756002868 | Texas | $8,571 | Medical Research |
| University of Alabama at Birmingham | |||||||
| 1720 2nd Ave South AB 990 | Birmingham | AL | 35294 | 636005396 | Alabama | $20,726 | Medical Research |
| University of California The Regents of | |||||||
| Accounting Office CGA Box 0897 | San Francisco | CA | 941430897 | 946002123 | 501c3 | $48,350 | Medical Research |
| University of California San Francisco | |||||||
| Accounting Office - CGA Box 0897 | San Francisco | CA | 941430897 | 946036493 | 501c3 | $5,853,939 | Medical Research |
| University of California Davis The Regents of | |||||||
| Cashiers Office PO Box 989062 | West Sacramento | CA | 957989062 | 946036494 | 501c3 | $21,973 | Medical Research |
| University of Chicago | |||||||
| Section Of Endocrinology 5841 S Mar | Chicago | IL | 60637 | 362177139 | 501c3 | $114,253 | Medical Research |
| University of Colorado-Denver | |||||||
| Office of Grants and Contracts F-42 | Denver | CO | 802910238 | 846049811 | 501c3 | $433,111 | Medical Research |
| University of Florida Board of Trustees | |||||||
| PO Box 113001 | Gainesville | FL | 32611 | 596002052 | 501c3 | $381,227 | Medical Research |
| University of Maryland Baltimore | |||||||
| Sponsored Projects Acctng 220 Arch | Baltimore | MD | 212011508 | 526002033 | Maryland | $23,726 | Medical Research |
| University of Massachusetts Worcester | |||||||
| 55 Lake Avenue North | Worcester | MA | 016550002 | 043167352 | Massachusetts | $40,313 | Medical Research |
| University of Michigan | |||||||
| Attnthe Regents of Box 223131 | Pittsburgh | PA | 152512131 | 386006309 | 501c3 | $21,886 | Medical Research |
| University of Michigan Regents of the | |||||||
| Box 223131 SSC Accounts Receivable | PIttsburgh | PA | 152512131 | 386006309 | 501c3 | $69,859 | Medical Research |
| University of Nebraska Medical Center | |||||||
| 985045 Nebraska Medical Center | Omaha | NE | 681985045 | 470049123 | 501c3 | $92,947 | Medical Research |
| University of North Carolina | |||||||
| 720 Martin Luther King Jr Blvd CB16 | Chapel HIll | NC | 27599 | 566001393 | 501c3 | $615,371 | Medical Research |
| University of North Carolina at Chapel Hill | |||||||
| 104 Airport Drive Suite 2200 CB1350 | Chapel HIll | NC | 27599 | 566001393 | 501c3 | $87,086 | Medical Research |
| University of Pennsylvania | |||||||
| PO Box 785541 | Philadelphia | PA | 171785541 | 231352685 | 501c3 | $190,055 | Medical Research |
| University of Pittsburgh | |||||||
| Division of Endocrinology E1140 Bio | Pittsburgh | PA | 15213 | 250965591 | 501c3 | $96,739 | Medical Research |
| University Of South Florida | |||||||
| PO Box 864568 | Orlando | FL | 328864568 | 593102112 | Florida | $12,747 | Medical Research |
| University of Texas Southwestern Medical Center | |||||||
| Lock Box 845477 | Dallas | TX | 752845477 | 756002868 | Texas | $21,262 | Medical Research |
| University of Utah | |||||||
| Utah Diabetes Center 615 Arapeen D | Salt Lake City | UT | 84108 | 876000525 | 501c3 | $28,052 | Medical Research |
| University of WA Grants | |||||||
| 12455 Collections Drive | Chicago | IL | 606930001 | 916001537 | Washington | $270,724 | Medical Research |
| University of Wisconsin Madison Board of Regents | |||||||
| 21 N Park St Ste 6401 | Madison | WI | 53792 | 396006492 | 501c3 | $128,078 | Medical Research |
| Vanderbilt University | |||||||
| Department of Finance Dept AT 40303 | Atlanta | GA | 311920303 | 620476822 | 501c3 | $10,876 | Medical Research |
| Wake Forest University Health Sciences | |||||||
| Medical Center Boulevard | WinstonSalem | NC | 27157 | 223849199 | 501c3 | $23,588 | Medical Research |
| Washington University in St Louis | |||||||
| 700 Rosedale Avenue Campus Box 1034 | St Louis | MO | 63012 | 460653611 | 501c3 | $11,890 | Medical Research |
| Winthrop University Hospital | |||||||
| Dept of Finance 700 Hicksville Road | Bethpage | NY | 11714 | 111633486 | 501c3 | $15,694 | Medical Research |
| Yale University | |||||||
| Grant and Contract Financial Admini | New Haven | CT | 065081873 | 080648973 | 501c3 | $208,218 | Medical Research |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 69 | Total501c3OrgCnt |
| Total Other Org | 5 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Part I Line 2 | FormAndLineReferenceDesc |
| Explanation | Subrecipient Monitoring Policy-medical research subawards-BRI has formal policies and procedures to assure full compliance with applicable policies and laws governing Federal Grants. The Subrecipient Monitoring Policy provides assurance that subrecipients comply with Federal Grant regulations. This policy sets the criteria to establish eligibility of subrecipients to provide annual audited financial reports and the annual OMB single audit report that identify compliance with federal laws and regulations. The reports are analyzed with emphasis on auditors assessment of subrecipient internal controls and a standardized Risk Assessment is presented to management on each subrecipient. A Management Letter is issued to each subrecipient showing any findings on their OMB single audit report, and measurements are set for increased monitoring when an elevated level of risk is established. Management has communicated with an educated administrative staff regarding implementation of this policy. The Director of Grants and Contracts is responsible for monitoring subrecipient adherence to financial regulations. The principal investigator is responsible for overseeing the satisfactory performance of the sub-award to ensure that goals are achieved. Unusual or unforeseen items will be investigated. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| First Class Or Charter Travel | Yes (X) | FirstClassOrCharterTravelInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (true) | SubstantiationRequiredInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Carla Greenbaum MD | |||||||||||
| Director | $212,388 | $24,000 | $6,886 | $243,274 | |||||||
| Gerald Nepom MD PhD | |||||||||||
| Ex Officio, Director | $389,687 | $42,000 | $2,592 | $523,675 | $89,396 | ||||||
| Joyce Lammert MD PhD | |||||||||||
| Director | $443,634 | $112,527 | $19,528 | $74,702 | $9,427 | $659,818 | |||||
| John Corman MD | |||||||||||
| Director | $505,321 | $175 | $18,550 | $18,054 | $21,300 | $563,400 | |||||
| Gary Kaplan MD | |||||||||||
| Director | $1,040,152 | $403,531 | $19,660 | $1,081,178 | $42,468 | $2,586,989 | |||||
| Homer Lane Jr | |||||||||||
| Executive Director, Chief Financial Officer | $249,016 | $24,000 | $8,594 | $339,998 | $58,388 | ||||||
| Jane Buckner MD | |||||||||||
| Research Member | $259,514 | $24,000 | $2,892 | $286,406 | |||||||
| William Kwok PhD | |||||||||||
| Research Member | $216,089 | $24,000 | $2,892 | $243,723 | $742 | ||||||
| Lynn Rose | |||||||||||
| Director Scientific Administration | $181,479 | $18,528 | $4,992 | $205,541 | $542 | ||||||
| Steven Ziegler PhD | |||||||||||
| Research Member | $188,567 | $14,392 | $4,104 | $207,605 | $542 | ||||||
| James Lord MD | |||||||||||
| Research Member | $202,127 | $17,634 | $3,804 | $223,565 | |||||||
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Part I Line 3 | Benaroya Research Institute at Virginia Mason relies upon Virginia Mason Medical Centers a related organization Board Compensation and Benefits committee, a committee composed of independent board members to whom the Board has delegated the authority to approve all compensation and benefits for the executive leaders of the Medical Center. To ensure that such benefit plans are market competitive and reasonable, the Committee receives support and advice, including appropriate market comparability data, from an independent compensation consultant with expertise in the health care industry and access to relevant market data. See Schedule O for additional disclosure. |
| Part I Line 4b | The Medical Center has a Supplemental Executive Retirement Plan SERP. The SERP is a 457f nonqualified deferred compensation plan pursuant to which plan benefits are subject to a substantial risk of forfeiture, entered into when certain senior executives join the Medical Center. The plan was approved by the Boards Compensation and Benefits Committee, a committee composed of independent board members to whom the board delegates the authority to approve compensation and benefits for the Medical Centers most senior executives. The Committee receives advice from an independent compensation consultant to ensure that compensation and benefits, including the SERP, are market competitive and reasonable. |
Schedule K IRS990ScheduleK
Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
Issuer Name IssuerName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | WA Econ Devel Fin Auth-2012 Series B | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Issuer EIN | 911493002 | BondIssuerEIN |
| Bond Issued | 2012-06-01 | BondIssuedDt |
| Issue Price | $10,390,000 | IssuePriceAmt |
| Purpose | See Part VI | PurposeDesc |
| Defeased | false | DefeasedInd |
| On Behalf Of Issuer | Yes (true) | OnBehalfOfIssuerInd |
| Pool Financing | false | PoolFinancingInd |
Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Retired | $965,000 | RetiredAmt |
| Total Proceeds | $10,390,348 | TotalProceedsAmt |
| Capital Expenditures | $2,550,348 | CapitalExpendituresAmt |
| Other Spent Proceeds | $7,840,000 | OtherSpentProceedsAmt |
| Substantial Completion | 2013 | SubstantialCompletionYr |
| Current Refunding | Yes (true) | CurrentRefundingInd |
| Advance Refunding | false | AdvanceRefundingInd |
| Final Allocation Made | Yes (true) | FinalAllocationMadeInd |
| Adequate Books And Rec Maint | Yes (true) | AdequateBooksAndRecMaintInd |
Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Owning Bond Financed Property | false | OwningBondFinancedPropertyInd |
| Any Lease Arrangements | Yes (true) | AnyLeaseArrangementsInd |
| Mgmt Contract Bond Fincd Prop | false | MgmtContractBondFincdPropInd |
| Any Research Agreements | Yes (true) | AnyResearchAgreementsInd |
| Engage Bond Counsel Research | Yes (true) | EngageBondCounselResearchInd |
| Private Bus Use By Others | 0.01690 | PrivateBusUseByOthersPct |
| Total Private Business Use | 0.01690 | TotalPrivateBusinessUsePct |
| Bond Iss Meet Prvt Sec Pymt Test | false | BondIssMeetPrvtSecPymtTestInd |
| Change In Use Bond Financed Prop | false | ChangeInUseBondFinancedPropInd |
| Procs Nonqualified Bond Remdtd | Yes (true) | ProcsNonqualifiedBondRemdtdInd |
Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Form8038 T Filed | false | Form8038TFiledInd |
| Rebate Not Due Yet | Yes (true) | RebateNotDueYetInd |
| Variable Rate Issue | false | VariableRateIssueInd |
| Hedge Identified In Bks And Rec | false | HedgeIdentifiedInBksAndRecInd |
| Gross Proceeds Invested In GIC | false | GrossProceedsInvestedInGICInd |
| Gross Proceeds Invested | false | GrossProceedsInvestedInd |
| Written Proc To Monitor Reqs | Yes (true) | WrittenProcToMonitorReqsInd |
Procedures Corrective Action ProceduresCorrectiveActionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bond Reference | A | BondReferenceCd |
| Procedures Corrective Action | Yes (true) | ProceduresCorrectiveActionInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Part I Line A Column F | Purposes to currently refund WEDFA Series 2006C bonds issued 11/15/2006, and to fund research facility improvements. |
| Part II Line 3 | Difference between Part I, column e and Part II, Line 3 is investment earnings. |
Schedule M IRS990ScheduleM
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | Advertising | Desc |
| Contribution | 1 | ContributionCnt |
| Noncash Contributions Rpt F990 | $85,000 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | Donor Valuation | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | false | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Part I Line 25 | FormAndLineReferenceDesc |
| Explanation | BRI received donated billboard space for BRI ads | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (12 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Form 990, Part III, Line 1 | Benaroya Research Institute at Virginia Mason BRI is a world-renowned medical research institute whose work has resulted in major advances against autoimmune and immune-mediated diseases. BRI is affiliated with the Virginia Mason Health System, that provides governance oversight and development support by its division the Virginia Mason Foundation. In 2015, BRI researchers generated 78 scientific publications that were published in prestigious research journals and delivered 75 presentations at domestic and international research conferences. One in 20 Americans suffers from one or more autoimmune diseases, such as type 1 diabetes, multiple sclerosis, Crohns disease and rheumatoid arthritis to name a few, and more than one out of every four Americans suffer from diseases of the immune system, such as allergies and asthma. Because these diseases are connected in the way the immune system attacks the body, BRI scientists arent focused on eliminating one or two immune system diseases - they are taking on many more. As a world leader in scientific innovation, BRIs discoveries are having significant impact on people living with these diseases today - by improving the ability to predict disease risk, decreasing disease progression and making therapies safer and better. |
| Form 990, Part III, Line 4 | One of the unique qualities of BRI is the close integration of three types of medical research - laboratory research, translational research and clinical research - to improve peoples lives. Our scientists can address both the basic science issues and clinical applications, which is the best way to design studies with the highest potential for success. For BRI, discovery starts in the laboratory. 2015 advancements in translational research, immunology, clinical research and other areas are highlighted below. |
| Form 990, Part III, Line 4a | Funding for the Immune Tolerance Network ITN was awarded to BRIs Dr. Jerry Nepom in 2014 from the National Institute of Allergy and Infectious Disease NIAID of the National Institutes of Health NIH. The 7-year award, totaling 27 million annually supports the ITN, a research consortium established in 1999 with a primary focus on the development of new tolerogenic approaches for the treatment and prevention of disease in three clinical areas asthma and allergic diseases autoimmune diseases and immune-mediated rejection of transplanted solid organs, tissues and cells. As the Prime recipient of this grant BRI is responsible for the management of the overall grant from NIAID including oversight of all aspects of the Networks infrastructure. The major activities in 2015 were diverse, but centered on preserving the ITNs cohesive project focused environment and its framework which has proven so successful in the management of a large cooperative agreement grant. Key outcomes in 2015 include the following 1 Cross Network Integration A top priority in this reporting period was to continue the successful ITN infrastructure which is spread across three main operational sites. This required careful planning and collaboration as the ITNs major centers of operations are geographically diverse, located in Seattle, San Francisco and Bethesda. Very few changes were made to the existing network integration as the current model continues to successfully support the overall ITN program. Establishing new relationships and vital connections within the research community continued to be an ITN goal. 2 Operations and Clinical Trial Support The ITN program team at BRI issued 168 subawards in 2015 in support of 24 active ITN clinical trials and numerous supporting ITN mechanistic trials. 3 Supplemental Funding / Partnerships ITN central administration continued to focus on identifying additional opportunities for supplemental funding and/or funding partnerships. a Supplemental Funding Opportunities The ITN Program Team at BRI submitted three supplemental funding requests in 2015. All three were awarded bringing in additional funding to the ITN BRI. b Partnerships The ITN continued its relationship with pharmaceutical partners for partial funding for two ITN studies with NIAID as the clinical sponsor. 4 Publication Activity In 2015, 38 ITN publications were published in prestigious research journals and were presented at domestic and international research conferences. These publications represented ITN research in all therapeutic focus areas of the ITN Type 1 Diabetes, Transplant, Autoimmune disease and Allergy and Asthma. |
| Form 990, Part III, Line 4b | Translational research is a scientific approach that moves findings from the bench to the bedside and back in an expedient and systematic way. It translates new laboratory discoveries quickly into medical practices. Clinician findings are in turn shared with laboratory scientists to bring medical research full circle. This transfer of knowledge between laboratory scientists and physicians leads to improved patient care, health and well-being. The research emphasis of the BRI Translational Research Program is the area of immune-mediated disease. BRI scientists and collaborators work together to study blood and serum samples along with medical and demographic data collected from people with autoimmune and immune-mediated diseases. These include multiple sclerosis, type 1 diabetes, lupus, rheumatoid arthritis, inflammatory bowel disease, allergy and asthma. BRI maintains an extensive biorepository with samples dating back to 2000, including 7 disease categories and a biorepository of healthy people for comparison purposes. Advancements in 2015 include the following 1 New Biorepository Data Management system - The research technology team at BRI finalized a two-year project to make BRIs data infrastructure more modern, powerful, and flexible. The new system dramatically improves how BRI researchers find, use and analyze information. The team imported data on approximately 9,000 participants and 25,000 samples. All samples and health information used by scientists are de-identified and coded with a number. 2 Connecting Cancer to Immunotherapy Research - In addition to autoimmune disease research, BRI scientists are making advances in other diseases of the immune system. Clinical immunotherapies for cancer treatment are actively being investigated, as well as basic research focused on understanding how aspects of the immune system might be harnessed to fight cancer. In a new collaboration, BRI has partnered with Virginia Mason and Bristol Meyers Squibb in an agreement to develop a new tumor biorepository. It will include tissue, blood samples and demographic data from Virginia Mason cancer patients and will initially focus on archiving biosamples from pancreatic, colorectal, lung and breast tumors. 3 Translational Research Symposium -- the first annual Clinical and Translational Research Symposium, sponsored by the Wilske Center for Translational Research, took place at Virginia Mason Medical Center. The event connected researchers and clinicians by highlighting the range of clinical and translational research being conducted at Virginia Mason and BRI. Of the more than 100 research abstracts submitted, the Wilske committee selected the top eight abstracts for oral presentations. 4 Food Allergy Research -- Funding was received from Food Allergy Research Education FARE to identify and isolate the T cells that cause peanut allergy. The genes used by these T cells will be studied to understand why these cells are causing allergies. This information will then be used to discover how to effectively neutralize these cells and cure peanut allergy. 5 New Translational Research Scientist - Marc Gavin, PhD, joined BRIs Translational Research Program. Dr. Gavins laboratory is focused on understanding how therapeutic manipulation of the balance between regulatory and effector T cells alters immune responses in setting of pathogenic inflammation, chronic infection, and cancer. His group is also investigating how variation in the availability and usage of interleukin-2 impacts the regulatory/effector T cell balance in human autoimmune disease. |
| Form 990, Part III, Line 4c | BRI is dedicated to seeking ways to eliminate type 1 diabetes, while at the same time looking for therapies to prevent, reverse and intervene in the disease at all stages. BRI is an international leader in type 1 diabetes research and has investigated it for more than 30 years, starting with identification of a genetic marker for the disease. Progress in 2015 includes 1 Leadership of Diabetes Network -- BRI became the leader of Type 1 Diabetes TrialNet, a National Institutes of Health-funded clinical trial network for type 1 diabetes prevention and early treatment. Carla Greenbaum, MD, director of BRIs Diabetes Research Program, was named chair of TrialNet. BRI also became the TrialNet Hub. The hub includes 21 clinical centers working in cooperation with more than 200 screening and clinical research sites through the United States and seven other countries. 2 EXTEND Study -- A new Immune Tolerance Network ITN type 1 diabetes trial was launched. The principal investigators are BRI scientists Carla Greenbaum, MD, and Jane Buckner, MD. The EXTEND trial Preserving Beta-Cell Function with Tocilizumab in New Onset Type 1 Diabetes will test whether tocilizumab ACTEMRA Genentech, an antibody that targets the interleukin-6 IL-6 receptor, can slow disease progression and help maintain natural insulin production in adults with new-onset type 1 diabetes. There are presently no treatments that can permanently halt or reverse the autoimmune-mediated destruction of insulin-producing beta cells in patients with type 1 diabetes. |
| Form 990, Part III, Line 4d | 1 Clinical Research Program Benaroya Research Institute oversees all clinical research at Virginia Mason Medical Center and BRI, ensuring consistent application of the federal regulations governing human subject research. The Clinical Research Program CRP includes the BRI Institutional Review Board IRB, which reviews and approves all investigator-initiated clinical research conducted at BRI and the Virginia Mason Medical Center VMMC. The CRP Administrative group CRPA contributes to and maintains a clinical quality assurance program designed to ensure regulatory and financial compliance to applicable regulations and internal policies. The CRPA also maintains a cadre of highly trained clinical research staff who work closely with individual investigators at VMMC. This partnership ensures a consistent and compliant approach to the implementation of clinical studies at VMMC. Active studies span a wide variety of diseases and conditions, including cardiology, neurology, anesthesiology, and cancer. In 2015, CRPA staff enrolled over 5,000 participants into 440 open studies. Approximately 170 research investigators are conducting human subject research at VMMC. The IRB was responsible for the initial or continuing review of over 500 studies. 2 Immunology Research Program a Technology Pipeline --BRI is conducting new research to discover and interrogate the rare cells that cause autoimmune diseases to improve diagnosis and therapy. The Institute is using several of its unique and pioneering technologies together to create a technology pipeline approach to find and study these rare cells. Scientists finding key molecular patterns of the cells in individuals who have immune-mediated diseases and those patterns that determine who responds to treatment. b The Kwok laboratory extended studies of allergic T lymphocytes using tetramer technologies to include description of cells associated with walnut and cat allergies. c Dr. Bettellis laboratory used a model of multiple sclerosis to change the movement of immune cells into the central nervous system, identifying keytrafficking molecules that influence disease progression. d Dr. Peter Linsley, leading BRIs systems immunology group, characterized transcriptional profiles that distinguished immune response patterns for a dozen different tumor types, identifying tumor-specific checkpoints that correlate with the patients prognosis. 3 Matrix Biology Research Program Collaborative studies between investigators in BRIs matrix biology and immunology programs used an oral inhibitor to successfully interrupt deposition of tissue matrix molecules for prevention of autoimmune diabetes in a model system. |
| Form 990, Part VI, Section A, Line 1a | The governing body delegates to an Executive Committee comprised of four officers of the Board and the Chairs of each standing Board Committee, the authority of the Board of Directors in the management of the corporation as may be deemed by the Executive Committee to be appropriate, to be exercised in time periods between regularly scheduled meetings of the Board of Directors provided that the Executive Committee has the authority to act only in time sensitive or emergency situations. The Director and the Executive Director of the corporation serve as ex officio members of the Executive Committee without voting rights. The Executive Committee does not have the authority to amend, alter or repeal the bylaws elect, appoint or remove any member of such Executive Committee or any director or officer of the corporation amend the articles of incorporation adopt a plan of merger or adopt a plan of consolidation with another corporation authorize the sale, lease or exchange of all or substantially all the property and assets of the corporation not in the ordinary course of business authorize the voluntary dissolution of the corporation or revoke proceedings therefore adopt a plan for the distribution of the assets of the corporation or amend, alter or repeal any resolution of the Board which by its terms provides that it shall not be amended, altered or repealed by such Executive Committee. The Executive Committee also serves as the planning committee for the Board of Directors and oversees any compliance issues raised by the Board of Directors. |
| Form 990, Part VI, Section A, Line 6, 7 | Virginia Mason Health System VMHS is the sole corporate member of Benaroya Research Institute at Virginia Mason BRI. VMHS as the sole voting member has the following approval rights a election or appointment of Directors and Officers of the Board of Directors b removal of Directors and Officers of the Board of Directors including any executive officer of the corporation c approval of all long-range and short-range plans proposed by the Board of Directors d approval of the annual capital and operating budgets proposed by the Board of Directors e approval of the borrowing of funds where the amount borrowed is in excess of Five Hundred Thousand Dollars 500,000 f approval of the sale, lease, exchange, mortgage, pledge or disposal of all or substantially all of the property and assets g approval of all amendments to or repeal of the Agreement Association or the Bylaws of the corporation h all other rights and powers as specified in the Washington Nonprofit Corporation Act. |
| Form 990, Part VI, Section B, Line 11b | The Virginia Mason Health System Audit and Compliance Committee ACC, a committee composed of independent community members has been delegated responsibility for oversight of the annual Form 990 preparation process including a selection, engagement, and review of the performance of the independent tax preparer b review of the annual draft Form 990 tax return, and c recommendation of the final Form 990 tax return for review to the BRI Board of Directors. Annually, at the September meeting, management and the tax preparer provides the ACC with an initial draft of the Form 990 and present an overview of the Form 990 preparation process. The final draft Form 990 is reviewed and approved by the ACC in November followed by a Board review of the final Form 990 prior to filing. The final Form 990 tax return is provided to each member of the Board of Directors via electronic delivery. |
| Form 990, Part VI, Section B, Line 12c | The Virginia Mason Health System Governance Committee has been delegated accountability for oversight of the process for disclosure, evaluation and management of conflict of interest involving any member of the Benaroya Research Institute at Virginia Mason BRI Board of Directors, executive leadership or key employees Covered Person. Pursuant to the Conflict of Interest Policy, an annual conflict of interest questionnaire is distributed to all Covered Persons. In addition, a Covered Person has an on-going duty to disclose the existence of a conflict of interest at any time an actual or potential conflict arises. Each Covered Person is required upon appointment and annually thereafter to attest to a statement that affirms that such person has a received a copy of the Conflict of Interest Policy b has read and understands the Policy c has agreed to comply with the Policy and d understands that BRI is a charitable organization and that in order to maintain its federal tax exemption must engage in activities that accomplish its tax-exempt purposes. Written disclosures are reviewed by the Governance Committee to determine if an actual or potential conflict of interest exists and if so, how it should be managed. The Covered Person is informed in writing regarding the determination the Conflict of Interest Management Plan. No Covered Person with an actual or potential conflict of interest shall engage in an activity on BRIs behalf related to the disclosed actual or potential Conflict of Interest unless such activity is permitted by the Conflict of Interest Management Plan or until the Covered Person has undertaken all steps set forth in the Management Plan to manage, reduce or eliminate the conflict. All Covered Persons have a duty to disclose the existence of any actual or potential conflict of interest with respect to meeting agenda items. The Conflict of Interest Policy requires that copies of the Conflict of Interest Questionnaire be completed annually by each covered Person and any Conflict of Interest Management Plan be maintained. |
| Form 990, Part VI, Section B, Line 15 | The VMHS Compensation and Benefits Board Committee, a committee composed solely of independent directors none of whom have a conflict of interest, is accountable for setting reasonable total compensation packages for each executive, officer and key employee Executive consistent with BRIs compensation philosophy and principles. The Committee approves annual goals and performance criteria which are used in determining merit increases and variable compensation opportunities. The Committee assesses performance against these goals. The Committee selects and engages a qualified independent compensation consultant to review and analyze the total compensation and benefits packages of the Executives. The Committee as part of its analysis obtains from the compensation consultant appropriate comparability data including total compensation paid by similarly situated organizations for positions that are functionally comparable to each of the Executives. The Committee will consider the significant terms of the agreement with each Executive including the total compensation to be paid and the employees duties and responsibilities. Consistent with the compensation philosophy and principles, the Committee approves total compensation packages for each of the Executives based on information presented to the Committee, reasonableness and the best interest of BRI. The Committees decisions regarding compensation for each Executive are documented in written resolutions and minutes of the Committee. The Committee promptly reports its actions to the VMHS board which reports are reflected in the Boards minutes. The individual positions who were reviewed in 2015 were the Board Director, Carla Greenbaum, BRI Director, and Executive Director and Chief Financial Officer. |
| Form 990, Part VI, Section C, Line 19 | The organizations Articles, Bylaws, Conflict of Interest Policy and financial statements are made available upon request. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Direct Controlling NADirectControllingNACd | Controlled OrganizationControlledOrganizationInd | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Virginia Mason Health System (VMHS) | |||||||||||
| 1100 Ninth Ave | Seattle | WA | 98101 | 911351110 | Fundraising | WA | Sec 501c3 | 7 | N/A | Yes (true) | |
| Virginia Mason Medical Center | |||||||||||
| 1100 Ninth Ave | Seattle | WA | 98101 | 910565539 | Health Care | WA | Sec 501c3 | 3 | false | VMHS | |
| Virginia Mason Institute | |||||||||||
| 1100 Ninth Ave | Seattle | WA | 98101 | 263763656 | Education/Research | WA | Sec 501c3 | 9 | false | VMMC | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | Yes (true) | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (true) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (true) | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (true) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (true) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Affiliated Group Schedule AffiliatedGroupSchedule
Affiliated Schedule AffiliatedScheduleGrp (4 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Total Grassroots LobbyTotalGrassrootsLobbyAmt | Total Direct LobbyTotalDirectLobbyAmt | Total Lobby ExpenditureTotalLobbyExpenditureAmt | Other Exempt Purpose ExpendOtherExemptPurposeExpendAmt | Total Exempt Purpose ExpendTotalExemptPurposeExpendAmt | Lobby NontxLobbyNontxAmt | Grassroots NontxGrassrootsNontxAmt | Total Lobby Grssroot Mns NontxTotalLobbyGrssrootMnsNontxAmt | Tot Lbby Expend Mns Lobby NontxTotLbbyExpendMnsLobbyNontxAmt | Share Excess Lobby ExpendShareExcessLobbyExpendAmt | Electing OrganizationElectingOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Benaroya Research Institute at Virginia Mason | |||||||||||||||
| 1201 Ninth Avenue | Seattle | WA | 98101 | 910653422 | $0 | $0 | $0 | $67,482,221 | $67,482,221 | $60,624 | $15,156 | $0 | $0 | $0 | |
| Virginia Mason Medical Center | |||||||||||||||
| 1100 Ninth Avenue | Seattle | WA | 98101 | 910565539 | $108,173 | $46,593 | $154,766 | $1,024,957,778 | $1,025,112,544 | $920,931 | $230,233 | $0 | $0 | $0 | Yes (X) |
| Virginia Mason Health System | |||||||||||||||
| 1100 Ninth Avenue | Seattle | WA | 98101 | 911351110 | $0 | $0 | $0 | $14,005,171 | $14,005,171 | $12,582 | $3,146 | $0 | $0 | $0 | |
| Virginia Mason Institute | |||||||||||||||
| 1100 Ninth Avenue | Seattle | WA | 98101 | 263763656 | $0 | $0 | $0 | $6,526,468 | $6,526,468 | $5,863 | $1,466 | $0 | $0 | $0 | |